Open Internet by MindsNet

Uncertainty in GLP-1 Medications' Effectiveness on Dementia

The relationship between GLP-1 medications and dementia risk is complex and not fully understood. Existing data is mixed, with some studies showing a significant reduction in dementia risk while others, like the EVOKE trial, show no effect. The mechanisms behind GLP-1's potential neuroprotective benefits are not clear, and there is a need for more research to understand its effects.

Science, Medicine, Pharmacology